Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανάπτυξη, χαρακτηρισμός και σταθερότητα μορφών φαρμάκων μικρής υδατοδιαλυτότητας με σύγχρονες μεθόδους

Abstract

dc:description

This Doctoral Thesis comprises separate chapters, each outlining different objectives, as explained below. In the first chapter, a systematic review of the current literature on co-amorphous drug delivery systems (CAMS) is performed. CAMS combine two or more initially crystalline, low-molecular-weight components to form a homogeneous single-phase amorphous system. Over the past few decades, they have been widely investigated as a promising approach to overcome the low water solubility of many active pharmaceutical ingredients. Most CAMS studies have been conducted case-by-case, and only a handful of systematic investigations exist. A quantitative analysis of the literature from several perspectives highlights not only the topics that have drawn the most attention, but also the developments still needed to advance the field. This review therefore offers an up-to-date, quantitative overview of published CAMS research, focusing on three critical quality attributes—co-formability, physical stability and dissolution performance. Specifically, we assess co-formability, the drug-to-co-former molar ratio, preparation methods, physical stability, and in-vitro and in-vivo performance. For each category, a quantitative assessment of the current state identifies both recent advances and remaining research gaps. Finally, emerging topics such as the design of ternary CAMS are discussed. In the second Chapter, co-amorphous systems (CAMS) were developed between griseofulvin (GRI) and L-leucine (LEU) at 2:1 wt ratio, by application of a novel solvent assisted hot-melt extrusion (HME) method that involved wet processing/drying of the feeds prior to extrusion. CAMS formation was confirmed by powder crystallography (pXRD) and thermal analysis (DSC). Intermolecular H-bonding between the carbonyl groups of GRI and the hydroxyl and amino groups of LEU were identified by vibrational spectroscopy (ATR-FTIR). The measured glass transition temperatures (Tg) of the extrudates from feeds processed with aqueous acetic acid (AcOH) were markedly lower than that of neat amorphous GRI and values predicted from Gordon-Taylor equation, indicating plasticizing action of AcOH. Drug concentrations during dissolution of CAMS under non-sink conditions (Sink Index 0.0115) were up to x82 higher at plateau compared to crystalline drug solubility. The degree of supersaturation lasted for at least 24 h. Plasticizer (Compritol®/Kolliphor® 75/25) added before extrusion did not impact significantly on CAMS formation but altered the dissolution profile from a spring-and-parachute profile to gradual rise to maximum. These findings reinforce the application of drug/amino acid-based CAMS in formulation, particularly for high-dose drugs, for which polymers are unsuited due to the required large proportions. In the third Chapter, CAMS of GRI with the amino acids (AA): L-lysine (LYS), L-valine (VAL) and L-methionine (MET) of increasing hydrophobicity were prepared using a solvent assisted hot-melt extrusion (HME). Co-formability was evaluated by thermodynamic miscibility prediction, thermal analysis (DSC), powder crystallography (pXRD) and vibrational spectroscopy (ATR-FTIR). Decomposition temperature range was defined by thermogravimetry (TGA) and DSC. Solubilities of crystalline and amorphous drug were determined by the UV-extinction method. The physical stability of GRI/AA CAMS was evaluated by accelerated tests and for ratios 1:1 and 1:2 was excellent. Non-sink dissolution tests of equimolar CAMS of the more hydrophobic MET and VAL revealed long lasting supersaturation, above the solubility of amorphous drug, whereas ratios 2:1 and 1:2 gave lower supersaturation due to partial recrystallization during dissolution, despite the good physical stability. CAMS of the hydrophilic LYS were physically stable but showed poor dissolution, possibly due to self-association of LYS in water. Addition of wetting agent in the dissolution medium improved dissolution without altering the profile. Since previous attempts to formulate GRI/AA CAMS with purely mechanical methods found only moderate success, the feed pretreatment HME method employed in this work makes an excellent alternative for drug/AA CAMS where mechanical or solvent evaporation methods fail. In the fourth Chapter, the development of CAMS of GRI with three AAs − L-lysine (GRI/LYS), L-methionine (GRI/MET), and L-valine (GRI/VAL) was investigated using the established methods of feed solvent pretreatment hot melt extrusion (mHME), ball milling (BM; dry and liquid-assisted), quench cooling (QC), and solvent evaporation (SE). The role of solvent treatment and thermal stress in mHME was elucidated. CAMS formation was evaluated using crystallography (pXRD) and modulated differential scanning colorimetry (DSC). Successful CAMS development was possible only with mHME emphasizing the importance of thermal stress. Hydrogen bonding was identified spectroscopically (ATR-FTIR) in the mHME and SE products by the disappearance of the 1658 cm−1 FTIR carbonyl peak indicating the important role of AcOH in feed pretreatment. Structural relaxation time of the developed CAMS was studied using thermal activity monitoring (TAM). Johari–Goldstein (β) secondary relaxation temperature was estimated using dynamic mechanical analysis (DMA). The structural relaxation time (τDβ), and the secondary relaxation temperature (Tgβ) of the developed CAMS increased in the order GRI/LYS < GRI/MET < GRI/VAL. Significant correlations exist between Tgβ and τDβ (R2 = 0.9922), and between Tgβ and the Hansen solubility parameters (R2 = 0.9965). The results of the in vitro dissolution/permeability test using the MicroFLUX™ system, in which the donor and receiver compartments are separated by a lipophilic membrane/hydrophilic filter barrier showed that GRI/VAL and GRI/MET CAMS gave significantly higher release and permeability compared to amorphous drug alone, due to the superior dissolution and sustained supersaturation. In the fifth Chapter, CAMS of exemestane (EXE) were prepared with three AA co-formers of increasing hydrophobicity: LYS, VAL and MET using feed solvent pretreatment hot-melt extrusion (mHME). Thermal analysis (DSC, TGA) guided processing parameters confirmed Class III glass-forming ability of EXE (Tg = 91.2 °C). Hansen solubility parameters (Δδt < 4 MPa1/2) predicted favorable drug/co- former miscibility. pXRD and DSC demonstrated successful co-amorphization for molar ratios of EXE/LYS (1:1 and 1:2), EXE/MET (1:1) and EXE/VAL (2:1 drug/AA). ATR-FTIR indicated co-amorphization predominantly by simple molecular mixing with weak only interactions. Physical stability of CAMS was evaluated by isothermal microcalorimetry, dynamic mechanical analysis (DMA) and by crystallographic profiles (pXRD) obtained at different times during accelerated stability tests (40 oC, 75% RH). EXE/LYS systems exhibited the longest relaxation times (τDβ) and highest secondary glass-transition temperatures (Tgβ), translating as excellent physical stability which corroborated the results of accelerated tests. EXE/MET showed moderate stabilization, while EXE/VAL was the least stable. Under non-sink conditions of dissolution test, EXE/LYS (1:1) presented a pronounced spring–parachute profile with sustained supersaturation, outperforming other EXE/AA CAMS. Strong correlations exist between Δδt, τDβ and Tgβ that underscore the utility of Hansen solubility parameters and relaxation metrics for predicting CAMS stability.In the sixth Chapter, equimolar GRI CAMS with three AA co-formers (LYS, MET and VAL) were prepared by mHME and were evaluated for their compaction performance and tablet physical stability. CAMS powders were compressed at three homologous temperatures (Th = 0.20, 0.40 and 0.80, corresponding to 22.5 oC, ≈ 45 oC and ≈ 90 oC compression temperatures). Compaction behavior was assessed from force–displacement profiles and Heckel model parameters; tablet strength and morphology from diametrical fracture tests and scanning electron microscopy images; moisture uptake and solid-state stability from dynamic vapor sorption, X-ray powder diffraction and micro-spatially offset low-frequency Raman spectroscopy. It was found that co-amorphization lowered the yield pressure of compacted CAMS powder from 121 MPa for crystalline GRI to 56-68 MPa, indicating markedly enhanced plasticity. Tablets produced at Th = 0.20 achieved the highest solid fraction (0.97–0.99) and tensile strength (1.4–1.7 MPa) with minimal elastic recovery. Compression at elevated temperatures did not further increase the tablet strength but halved the ejection force, thus, improving manufacturability. All co-amorphous tablets exhibited low hygroscopicity and remained fully amorphous after 90 days storage at 45 oC/75 % RH, in contrast to tablets of amorphous drug alone, which recrystallized within 30 days, thus, confirming excellent in-tablet stability of the CAMS. However, low-frequency Raman mapping detected isolated residual GRI crystals, suggesting that the equimolar ratio GRI/AA ratio is close to but not exactly the optimal molar ratio. These findings demonstrate the feasibility for direct compression of powdered griseofulvin / amino acid CAMS prepared by hot-melt extrusion into robust, stable tablets.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Partheniadis, Ioannis
  • Παρθενιάδης, Ιωάννης

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59493

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Partheniadis, Ioannis; Παρθενιάδης, Ιωάννης. Ανάπτυξη, χαρακτηρισμός και σταθερότητα μορφών φαρμάκων μικρής υδατοδιαλυτότητας με σύγχρονες μεθόδους. Aristotle University Of Thessaloniki (AUTH), 2025. http://hdl.handle.net/10442/hedi/59493